Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Tandem Diabetes Care Inc

TNDM ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Small Cap Analyst: BUY

Last Close

$22.72

▼ -1.77%

Market Cap $1.58B · Vol 433.04K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.58B

Small Cap

Div Yield

N/A

EPS Growth

+73.68%

YoY

RSI (14)

78.29

Momentum

Beta

1.57

vs Market

52W High

$29.65

23.37% below

52W Low

$10.26

121.44% above

Volume

433.04K

Avg 653.68K

P/B

9.67

Price-to-book

ROE

-83.01%

Return on equity

Free Float

98.82%

Public shares

Shariah Compliance8 STANDARDS

✗ Tandem Diabetes Care Inc (TNDM) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TNDM pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.52%

+46.20%

+60.57%

+19.89%

YTD

+3.37%

+113.13%

-21.33%

-78.81%

Financials & Valuation

TTM · Annual

Total Revenue	$1.01B
Net Income	$-204,710,000.00
Revenue Growth (YoY)	+5.77%
Gross Margin	53.81%
Operating Margin	-7.70%
Net Profit Margin	-20.17%
ROE	-83.01%
ROA · ROIC	-21.67% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.46
P/B	9.67
P/FCF	N/A
EPS Growth	+73.68%
Outstanding Shares	69.58M

Technical Indicators

50-Day SMA	$17.56
200-Day SMA	$19.35
RSI (14)	78.29
Beta	1.57
52-Week High	$29.65
52-Week Low	$10.26

Volume Today	433.04K
Avg Daily Volume (30D)	653.68K
Relative Volume	0.66x
Volatility (10D)	91.49
Volatility (30D)	66.41
Free Float	98.82%

Analyst Consensus

BUY

Current Price $22.72

Mean Target $29.16

52W Low$10.26 52W High$29.65

Current

Target

$10.26 $29.65

Current Analyst target

+28.34% upside potential · 23 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001TG5QC4

ISINUS8753722037

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.